Company profile: Zeptosens
1.1 - Company Overview
Company description
- Provider of ultra-sensitive microarray platforms for quantitative proteomic investigations, delivering sensitive, quantitative protein profiling and signaling pathway analysis via reverse protein arrays. Products include ZeptoREADER, a microarray reader for planar waveguide technology, and ZeptoMARK.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Zeptosens
Univercells
HQ: Belgium
Website
- Description: Provider of end-to-end, high-density, low-cost biomanufacturing solutions, including the NevoLine vaccine platform (incl. inactivated polio vaccine), scale-X single-use bioreactors, Exothera viral vector CDMO, custom bioproduction hubs with preclinical to commercial GMP capabilities, turnkey advisory for local site design/operation/regulatory compliance, and Ntensify RNA production in mobile labs; engineered to cut investments >75% and cost of goods up to 90%.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Univercells company profile →
Lightspeed Genomics
HQ: United States
Website
- Description: Provider of a high-speed DNA sequencing platform enabling faster, lower-cost human genome sequencing. The technology supports innovation in basic research, drug development, and medical diagnostics, driving advances in healthcare.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lightspeed Genomics company profile →
IBL International
HQ: Germany
Website
- Description: Provider of immunoassays and antibodies/in-vitro diagnostic assays for research, clinical, and specialty laboratories; develops, manufactures, and distributes assays focused on special and rare indications in endocrinology, neonatal screening, and the diagnosis of stress parameters and steroid hormones.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IBL International company profile →
SynHelix
HQ: France
Website
- Description: Provider of offerings aimed at breaking the bottleneck of biotherapeutics development by addressing the unsolved DNA constructs supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SynHelix company profile →
Tentarix
HQ: United States
Website
- Description: Provider of protein therapeutics and discovery platforms leveraging synthetic biology, including the Tentacles platform for multifunctional, conditionally active antibody-based biologics that activate immune cells and modulate disease while minimizing safety concerns; CellSurf to understand cell surface proteomes; HuTARG mammalian display to discover fully human binders; and FunctionSeq high-throughput screening of multifunctional biologics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tentarix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Zeptosens
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Zeptosens
2.2 - Growth funds investing in similar companies to Zeptosens
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Zeptosens
4.2 - Public trading comparable groups for Zeptosens
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →